Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus


  1. 2019
  2. Published

    Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study

    Buron, M. D., Chalmer, T. A., Sellebjerg, Finn Thorup, Fredriksen, Jette Lautrup, Góra, M. K., Illes, Z., Kant, M., Mezei, Z., Petersen, T., Rasmussen, P. V., Roshanisefat, H., Hassanpour-Kalam-Roudy, H., Sejbæk, T., Tsakiri, A., Weglewski, Arkadiusz, Sørensen, Per Soelberg & Magyari, M., 2019, In: Neurology. 92, 16, p. e1811-e1820

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy

    Members of Danish Multiple Sclerosis Group, M. O. D. M. S. G., Sellebjerg, Finn Thorup, Magyari, M., Blinkenberg, M., Oturai, A. B., Fredriksen, Jette Lautrup, Jensen, Michael Broksgaard, Tørring, J., Pfleger, C. C. & Weglewski, Arkadiusz, Feb 2019, In: Journal of Neurology. 266, 2, p. 306-315

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

    International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders, I. C. O. S. C. I. A. I. I. M. S. A. N. O. S. D., 2019, In: The Lancet Neurology. 18, 2, p. 185-197 13 p.

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis

    Comi, G., Cook, S., Giovannoni, G., Rieckmann, P., Sørensen, Per Soelberg, Vermersch, P., Galazka, A., Nolting, A., Hicking, C. & Dangond, F., 2019, In: Multiple Sclerosis and Related Disorders. 29, p. 168-174 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

    Giovannoni, G., Sørensen, Per Soelberg, Cook, S., Rammohan, K. W., Rieckmann, P., Comi, G., Dangond, F., Hicking, C. & Vermersch, P., May 2019, In: Multiple Sclerosis Journal. 25, 6, p. 819-827

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study

    On behalf of the ABIRISK Consortium, O. B. O. T. A. C., Jan 2019, In: Journal of Neuroimmunology. 326, p. 19-27

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Worsening of disability caused by relapses in multiple sclerosis: A different approach

    Koch-Henriksen, N., Thygesen, L. C., Sørensen, Per Soelberg & Magyari, M., Jul 2019, In: Multiple Sclerosis and Related Disorders. 32, p. 1-8

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    The changing course of multiple sclerosis: rising incidence, change in geographic distribution, disease course, and prognosis

    Magyari, M. & Sørensen, Per Soelberg, 2019, In: Current Opinion in Neurology. 32, 3, p. 320-326

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published

    Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

    Patsopoulos, N. A., Baranzini, S. E., Santaniello, A., Shoostari, P., Cotsapas, C., Wong, G., Beecham, A. H., James, T., Replogle, J., Vlachos, I. S., McCabe, C., Pers, T. H., Brandes, A., White, C., Keenan, B., Cimpean, M., Winn, P., Panteliadis, I. P., Robbins, A., Andlauer, T. F. M. & 32 others, Zarzycki, O., Dubois, B., Goris, A., Søndergaard, H. B., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Ullum, H., Thørner, L. W., Saarela, J., Cournu-Rebeix, I., Damotte, V., Fontaine, B., Guillot-Noel, L., Lathrop, M., Vukusic, S., Berthele, A., Pongratz, V., Buck, D., Gasperi, C., Graetz, C., Grummel, V., Hemmer, B., Hoshi, M., Knier, B., Korn, T., Lill, C. M., Luessi, F., Karpe, F., Lage, K., Oturai, A., International Multiple Sclerosis Genetics Consortium, I. M. S. G. C. & ANZgene, IIBDGC, WTCCC2, A. I. W., 2019, In: Science. 365, 6460, eaav7188.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis

    Petersen, E. R., Ammitzbøll, C., Søndergaard, H. B., Oturai, A. B., Sørensen, Per Soelberg, Nilsson, A. C., Börnsen, L., von Essen, Marina Rode & Sellebjerg, Finn Thorup, 2019, In: Journal of Neuroimmunology. 337, 577085.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 11025